Sientra, Inc. SIEN
We take great care to ensure that the data presented and summarized in this overview for Sientra, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SIEN
Top Purchases
Top Sells
About SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
Insider Transactions at SIEN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2023
|
Ronald Menezes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,625
-17.77%
|
$0
$0.71 P/Share
|
|
Nov 13
2023
|
Caroline F. Van Hove Director |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-8.25%
|
$0
$0.71 P/Share
|
|
Sep 07
2023
|
Oliver Christian Bennett GC & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,739
+10.6%
|
$2,739
$1.75 P/Share
|
|
Aug 03
2023
|
Andrew C Schmidt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
561
-1.18%
|
$1,683
$3.86 P/Share
|
|
Jun 15
2023
|
Mary Fisher Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+38.0%
|
-
|
|
Jun 15
2023
|
Philippe Schaison Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+34.55%
|
-
|
|
Jun 15
2023
|
Irina Erenburg Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+48.62%
|
-
|
|
Jun 15
2023
|
Alexander W. Casdin Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+5.62%
|
-
|
|
Jun 15
2023
|
Nori Ebersole Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+48.62%
|
-
|
|
Mar 22
2023
|
Andrew C Schmidt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,718
-1.06%
|
$2,718
$1.38 P/Share
|
|
Mar 22
2023
|
Oliver Christian Bennett GC & Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,070
-0.84%
|
$2,070
$1.38 P/Share
|
|
Mar 22
2023
|
Ronald Menezes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,725
-0.32%
|
$1,725
$1.38 P/Share
|
|
Jan 11
2023
|
Caroline F. Van Hove Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-1.2%
|
$0
$0.23 P/Share
|
|
Nov 10
2022
|
Ronald Menezes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,500
-6.32%
|
$0
$0.19 P/Share
|
|
Nov 10
2022
|
Caroline F. Van Hove Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,862
-4.19%
|
$0
$0.19 P/Share
|
|
Aug 03
2022
|
Andrew C Schmidt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,201
-2.37%
|
$0
$0.93 P/Share
|
|
Jun 09
2022
|
Nori Ebersole Director |
BUY
Grant, award, or other acquisition
|
Direct |
103,306
+45.51%
|
-
|
|
Jun 09
2022
|
Irina Erenburg Director |
BUY
Grant, award, or other acquisition
|
Direct |
103,306
+45.51%
|
-
|
|
Jun 09
2022
|
Mary Fisher Director |
BUY
Grant, award, or other acquisition
|
Direct |
103,306
+36.57%
|
-
|
|
Jun 09
2022
|
Kevin C Oboyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
103,306
+31.86%
|
-
|
Last 12 Months Summary
| Payment of exercise price or tax liability | 4.37K shares |
|---|